BHC
Price
$8.36Alerts
Change
+$0.06 (+0.72%)
Updated
Nov 11, 04:59 PM (EDT)
Capitalization
3.06B
104 days until earnings call
Intraday BUY SELL Signals
ZSTK
Price
$2.65Alerts
Change
+$0.12 (+4.74%)
Updated
Nov 11 closing price
Capitalization
55.8M
140 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BHC vs ZSTK

BHC vs ZSTK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BHC vs. ZSTK commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHC is a Buy and ZSTK is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BHC with price predictions
Nov 11, 2026

BHC in +5.53% Uptrend, advancing for three consecutive days on November 09, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where BHC advanced for three days, in 212 of 278 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

BHC moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BHC crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.

The Aroon Indicator entered an Uptrend today. In 115 of 155 cases where BHC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.

Bearish Trend Analysis

The 10-day RSI Indicator for BHC moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 30 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 56 cases where BHC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 75%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BHC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

BHC broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 2 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-1.727) is normal, around the industry mean (6.379). P/E Ratio (-2.782) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.011) is also within normal values, averaging (2.202). BHC has a moderately high Dividend Yield (0.489) as compared to the industry average of (0.062). P/S Ratio (0.197) is also within normal values, averaging (183.387).

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. BHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

A.I.Advisor
a Summary for ZSTK with price predictions
Nov 11, 2026

Momentum Indicator for ZSTK turns negative, indicating new downward trend

ZSTK saw its Momentum Indicator move below the 0 level on October 13, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned negative. In 78 of the 83 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for ZSTK turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In 38 of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

ZSTK moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ZSTK crossed bearishly below the 50-day moving average on October 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZSTK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for ZSTK entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ZSTK's RSI Oscillator exited the oversold zone, 25 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 20 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZSTK advanced for three days, in 187 of 219 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.038) is normal, around the industry mean (2.412). P/E Ratio (-0.059) is within average values for comparable stocks, (-2.386). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.319). Dividend Yield (0.000) settles around the average of (0.270) among similar stocks. P/S Ratio (0.772) is also within normal values, averaging (15.694).

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. ZSTK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZSTK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

FUNDAMENTALS RATINGS
BHC: Fundamental Ratings
BHC
OUTLOOK RATING
1..100
41
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BHCZSTK
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 10 days ago
77%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
74%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (BHC: $8.29 vs. ZSTK: $2.53)
Brand notoriety: BHC: Notable vs. ZSTK: Not notable
BHC represents the Pharmaceuticals: Generic, while ZSTK is part of the Investment Managers industry
Current volume relative to the 65-day Moving Average: BHC: 75% vs. ZSTK: 3%
Market capitalization -- BHC: $3.06B vs. ZSTK: $55.8M
BHC [@Pharmaceuticals: Generic] is valued at $3.06B. ZSTK’s [@Investment Managers] market capitalization is $55.8M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The market cap for tickers in the [@Investment Managers] industry ranges from $1.6 to $182.57B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.46B. The average market capitalization across the [@Investment Managers] industry is $8.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHC’s FA Score shows that 1 FA rating(s) are green while ZSTK’s FA Score has 0 green FA rating(s).

  • BHC’s FA Score: 1 green, 4 red.
  • ZSTK’s FA Score: 0 green, 5 red.
According to our system of comparison, BHC is a better buy in the long-term than ZSTK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHC’s TA Score shows that 4 TA indicator(s) are bullish while ZSTK’s TA Score has 3 bullish TA indicator(s).

  • BHC’s TA Score: 4 bullish, 4 bearish.
  • ZSTK’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BHC is a better buy in the short-term than ZSTK.

Price Growth

BHC (@Pharmaceuticals: Generic) experienced а +1.84% price change this week, while ZSTK (@Investment Managers) price change was -11.85% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.20%. For the same industry, the average monthly price growth was -6.54%, and the average quarterly price growth was +10.31%.

The average weekly price growth across all stocks in the @Investment Managers industry was -2.64%. For the same industry, the average monthly price growth was -2.86%, and the average quarterly price growth was -1.76%.

Reported Earning Dates

BHC is expected to report earnings on Feb 24, 2027.

ZSTK is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.20% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Investment Managers (-2.64% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

View a ticker or compare two or three
Interact to see
Advertisement

BHC and

Correlation & Price change

A.I.dvisor tells us that BHC and AMPH have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BHC and AMPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHC
1D Price
Change %
BHC100%
+0.72%
AMPH - BHC
30%
Poorly correlated
-1.58%
HCM - BHC
28%
Poorly correlated
-1.95%
ZSTK - BHC
25%
Poorly correlated
+4.74%
COLL - BHC
24%
Poorly correlated
+1.39%
ANIP - BHC
24%
Poorly correlated
-0.22%
More

ZSTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZSTK has been loosely correlated with SNDL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ZSTK jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZSTK
1D Price
Change %
ZSTK100%
+4.74%
SNDL - ZSTK
37%
Loosely correlated
+2.16%
ACET - ZSTK
34%
Loosely correlated
-0.33%
SXTC - ZSTK
26%
Poorly correlated
-1.74%
IMCC - ZSTK
26%
Poorly correlated
-6.05%
RMTI - ZSTK
24%
Poorly correlated
-3.15%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RDTL4.690.57
+13.83%
GraniteShares 2x Long RDDT Daily ETF (RDTL)
QBY4.670.06
+1.30%
GraniteShares YieldBoost QBTS ETF (QBY)
RFV147.691.17
+0.80%
Invesco S&P Midcap 400 Pure Value ETF (RFV)
BMOP24.250.03
+0.12%
BNY Mellon Municipal Opportunities ETF (BMOP)
PAYR56.79-0.03
-0.05%
Federated Hermes Enhanced Income ETF (PAYR)